ZA201408061B - Compositions and methods for the treatment of neurological disorders - Google Patents
Compositions and methods for the treatment of neurological disordersInfo
- Publication number
- ZA201408061B ZA201408061B ZA2014/08061A ZA201408061A ZA201408061B ZA 201408061 B ZA201408061 B ZA 201408061B ZA 2014/08061 A ZA2014/08061 A ZA 2014/08061A ZA 201408061 A ZA201408061 A ZA 201408061A ZA 201408061 B ZA201408061 B ZA 201408061B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- treatment
- methods
- neurological disorders
- neurological
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1789CH2012 | 2012-05-08 | ||
PCT/IB2013/050801 WO2013167989A2 (en) | 2012-05-08 | 2013-01-30 | Compositions and methods for the treatment of neurological disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA201408061B true ZA201408061B (en) | 2016-04-28 |
Family
ID=54193688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA2014/08061A ZA201408061B (en) | 2012-05-08 | 2014-11-04 | Compositions and methods for the treatment of neurological disorders |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2882427A2 (en) |
JP (1) | JP2015533114A (en) |
CN (1) | CN104797568A (en) |
AU (1) | AU2013257710B2 (en) |
CA (1) | CA2872976A1 (en) |
SG (1) | SG11201407310TA (en) |
WO (1) | WO2013167989A2 (en) |
ZA (1) | ZA201408061B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201407307YA (en) * | 2012-05-07 | 2014-12-30 | Cellix Bio Private Ltd | Prodrugs of anti-platelet agents |
CN104583162A (en) * | 2012-07-03 | 2015-04-29 | 塞利克斯比奥私人有限公司 | Compositions and methods for the treatment of moderate to severe pain |
CN114276516B (en) * | 2022-01-14 | 2022-11-18 | 浙江佳人新材料有限公司 | Method for preparing hard polyurethane foam by using byproducts of waste textile chemical method regeneration process |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL67623A (en) * | 1983-01-05 | 1984-09-30 | Teva Pharma | 1'-ethoxycarbonyloxyethyl ester of valproic acid,its preparation and pharmaceutical compositions containing it |
IT1190133B (en) * | 1986-06-19 | 1988-02-10 | Chiesi Farma Spa | VALPROIC ACID AND (E) -2-VALPROENOIC ACID DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS |
DE3726945A1 (en) * | 1987-08-13 | 1989-02-23 | Dietl Hans | L-Carnitine derivatives of valproic acid and pharmaceuticals containing these |
CN1187813A (en) * | 1995-05-01 | 1998-07-15 | 斯科舍集团有限公司 | Fatty acid esters as bioactive compounds |
MY118354A (en) * | 1995-05-01 | 2004-10-30 | Scarista Ltd | 1,3-propane diol derivatives as bioactive compounds |
US6313106B1 (en) * | 1995-06-07 | 2001-11-06 | D-Pharm Ltd. | Phospholipid derivatives of valproic acid and mixtures thereof |
MXPA00012808A (en) * | 1998-06-22 | 2002-04-24 | American Biogenetic Sciences | The use of valproic acid analog for the treatment and prevention of migraine and affective illness. |
US7544681B2 (en) * | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
US20040037880A1 (en) * | 2002-06-07 | 2004-02-26 | Pratik Kumar | Extended release formulation of divalproex sodium |
CN101619040B (en) * | 2008-07-04 | 2012-05-09 | 中国科学院上海药物研究所 | Aporphine compound, medicinal composition thereof and application thereof |
US20110212954A1 (en) * | 2008-11-07 | 2011-09-01 | Mario Brufani | Alpha-lipoic acid derivatives and their use in drug preparation |
-
2013
- 2013-01-30 EP EP13788559.6A patent/EP2882427A2/en not_active Withdrawn
- 2013-01-30 JP JP2015510895A patent/JP2015533114A/en active Pending
- 2013-01-30 CN CN201380030658.0A patent/CN104797568A/en active Pending
- 2013-01-30 CA CA2872976A patent/CA2872976A1/en not_active Abandoned
- 2013-01-30 AU AU2013257710A patent/AU2013257710B2/en not_active Expired - Fee Related
- 2013-01-30 WO PCT/IB2013/050801 patent/WO2013167989A2/en active Application Filing
- 2013-01-30 SG SG11201407310TA patent/SG11201407310TA/en unknown
-
2014
- 2014-11-04 ZA ZA2014/08061A patent/ZA201408061B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SG11201407310TA (en) | 2014-12-30 |
EP2882427A2 (en) | 2015-06-17 |
WO2013167989A3 (en) | 2016-08-25 |
JP2015533114A (en) | 2015-11-19 |
WO2013167989A2 (en) | 2013-11-14 |
CN104797568A (en) | 2015-07-22 |
AU2013257710B2 (en) | 2016-10-20 |
AU2013257710A1 (en) | 2014-11-27 |
CA2872976A1 (en) | 2013-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL266582A (en) | Compositions and methods for the treatment of hemoglobinopathies | |
IL239355A0 (en) | Gamma-hydroxybutyrate compositions and their use for the treatment of disorders | |
HK1210968A1 (en) | Compositions and treatment for eye diseases and disorders | |
EP2552433A4 (en) | Compositions and methods for the treatment of somatosensory disorders | |
EP2827856A4 (en) | Compounds and compositions for the treatment of muscular disorders | |
IL225239A0 (en) | Compositions for the treatment of acne and related disorders | |
HUE041553T2 (en) | Methods and compositions for the treatment of monogenic diseases | |
HK1198909A1 (en) | Compositions and methods for the treatment of hepatic diseases and disorders | |
RS56595B1 (en) | Estrogenic derivatives for use in the treatment of neurological disorders | |
EP2550361A4 (en) | Compositions and methods for treating neurological disorders | |
ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
IL239374B (en) | Compositions and methods for the treatment of brain cancers | |
EP2681209A4 (en) | Compounds and methods for the treatment of pain and other disorders | |
ZA201408060B (en) | Compositions and methods for the treatment of neurological disorders | |
ZA201408061B (en) | Compositions and methods for the treatment of neurological disorders | |
ZA201408058B (en) | Compositions and methods for the treatment of epilepsy | |
EP2825183A4 (en) | Herbal composition for the treatment of metabolic disorders | |
HK1207293A1 (en) | Composition for the treatment of inflammatory and immune disorders | |
ZA201408045B (en) | Compositions and methods for the treatment of inflammation and lipid disorders | |
GB201201779D0 (en) | Treatment of inflammatory disorders |